Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
May 16, 2018
Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive Performance
Andrew M Stein, Michael Looby
British Journal of Clinical Pharmacology
|
March 20, 2013
Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach
Christian Bartels, Michael Looby, Romain Sechaud, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
September 18, 2012
Comment on the report "limitations of model-based dose selection for indacaterol in patients with chronic obstructive pulmonary disease"
Michael Looby, Didier Renard, Andrew Wright, et al.
Journal of Clinical Pharmacology
|
November 24, 2011
Population pharmacokinetics of fingolimod phosphate in healthy participants
Kai Wu, Francois Mercier, Olivier J David, et al.
British Journal of Clinical Pharmacology
|
October 22, 2009
Population pharmacokinetics and optimal design of paediatric studies for famciclovir
Kayode Ogungbenro, Ivan Matthews, Michael Looby, et al.
Respiratory Research
|
April 27, 2011
Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches
Didier Renard, Michael Looby, Benjamin Kramer, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 25, 2010
Population pharmacodynamic model of the longitudinal FEV1 response to an inhaled long-acting anti-muscarinic in COPD patients
Kai Wu, Michael Looby, Goonaseelan Pillai, et al.
BMC Pulmonary Medicine
|
December 11, 2012
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
Helen Arievich, Tim Overend, Didier Renard, et al.
Clinical Pharmacokinetics
|
May 14, 2004
Pharmacokinetics of lumiracoxib in plasma and synovial fluid
Graham Scott, Christiane Rordorf, Christine Reynolds, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 25, 2021
A framework to guide dose & regimen strategy for clinical drug development
Oliver Sander, Baldur Magnusson, Inga Ludwig, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
CPT: Pharmacometrics & Systems Pharmacology
|
May 16, 2018
Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive Performance
Andrew M Stein, Michael Looby
British Journal of Clinical Pharmacology
|
March 20, 2013
Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach
Christian Bartels, Michael Looby, Romain Sechaud, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
September 18, 2012
Comment on the report "limitations of model-based dose selection for indacaterol in patients with chronic obstructive pulmonary disease"
Michael Looby, Didier Renard, Andrew Wright, et al.
Journal of Clinical Pharmacology
|
November 24, 2011
Population pharmacokinetics of fingolimod phosphate in healthy participants
Kai Wu, Francois Mercier, Olivier J David, et al.
British Journal of Clinical Pharmacology
|
October 22, 2009
Population pharmacokinetics and optimal design of paediatric studies for famciclovir
Kayode Ogungbenro, Ivan Matthews, Michael Looby, et al.
Respiratory Research
|
April 27, 2011
Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches
Didier Renard, Michael Looby, Benjamin Kramer, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 25, 2010
Population pharmacodynamic model of the longitudinal FEV1 response to an inhaled long-acting anti-muscarinic in COPD patients
Kai Wu, Michael Looby, Goonaseelan Pillai, et al.
BMC Pulmonary Medicine
|
December 11, 2012
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
Helen Arievich, Tim Overend, Didier Renard, et al.
Clinical Pharmacokinetics
|
May 14, 2004
Pharmacokinetics of lumiracoxib in plasma and synovial fluid
Graham Scott, Christiane Rordorf, Christine Reynolds, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 25, 2021
A framework to guide dose & regimen strategy for clinical drug development
Oliver Sander, Baldur Magnusson, Inga Ludwig, et al.
Page
of 2